Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Details Narrative)

v3.10.0.1
Stock-Based Compensation (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Aug. 04, 2018
Sep. 14, 2017
May 13, 2017
Sep. 14, 2016
May 13, 2016
Sep. 14, 2015
Dec. 24, 2013
Jun. 20, 2007
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Jun. 24, 2017
Jun. 24, 2016
Jun. 24, 2015
Jun. 24, 2014
Fair market value, per share                     $ 0.7500          
Stock based compensation                 $ 772,390 $ 15,960 $ 772,390 $ 37,701        
Stock options granted value                     772,390          
Total deferred compensation expense for outstanding value of unvested stock options                     44,000          
Intrinsic value of exercisable but unexercised in-the-money stock options                 $ 2,362,500   $ 2,362,500          
Stock option outstanding acquired common stock                 200,000   200,000          
Director [Member] | Dr. Stephen J. Forman [Member]                                
Stock options granted to purchase common stock         200,000                      
Stock options fully vested amount         $ 15,590                      
Stock price per share         $ 0.1559                      
Charges to operations                       5,681        
Number of fully vested option issued     100,000   100,000                      
Stock options are exercisable price per share         $ 0.16                      
Fair value of stock options         $ 31,180                      
Stock option vested exercisable term         5 years                      
Director [Member] | Dr. Winson Ho [Member]                                
Stock options granted to purchase common stock 200,000                              
Stock options fully vested amount $ 52,460                              
Stock price per share $ 0.2623                              
Charges to operations                 $ 60,652   $ 60,652          
Number of fully vested option issued 100,000                              
Stock options are exercisable price per share $ 0.28                              
Fair value of stock options $ 104,920                              
Stock option vested exercisable term 5 years                              
Director [Member] | Dr. Winson Ho [Member] | August 4, 2019 [Member]                                
Number of fully vested option issued                     100,000          
Director [Member] | Dr. Yun Yen [Member]                                
Stock options granted to purchase common stock 200,000                              
Stock options fully vested amount $ 52,460                              
Stock price per share $ 0.2623                              
Charges to operations                 60,652   $ 60,652          
Number of fully vested option issued 100,000                              
Stock options are exercisable price per share $ 0.28                              
Fair value of stock options $ 104,920                              
Stock option vested exercisable term 5 years                              
Director [Member] | Dr. Yun Yen [Member] | August 4, 2019 [Member]                                
Number of fully vested option issued                     100,000          
Mr. Schwartzberg [Member]                                
Stock based compensation                 $ 772,390   $ 772,390          
Stock options granted value                     $ 711,738          
Collaboration Agreement Bio PharmaWorks LLC [Member]                                
Charges to operations                   $ 15,960   29,528        
NDA Agreement [Member]                                
Stock options granted to purchase common stock             100,000                  
Number of stock options vested                         25,000 25,000 25,000 25,000
Options exercisable period             5 years                  
Options, exercisable price per share             $ 0.13                  
Stock options fully vested amount             $ 12,960                  
Stock price per share             $ 0.13                  
Charges to operations                       $ 2,492        
2007 Stock Compensation Plan [Member]                                
Number of restricted stock issued               2,500,000                
Stock options granted to purchase common stock                     1,350,000          
Collaboration Agreement Bio PharmaWorks LLC [Member]                                
Options, exercisable price per share           $ 0.26                    
Stock options fully vested amount           $ 260,000                    
Number of fully vested option issued           1,000,000                    
Collaboration Agreement Bio PharmaWorks LLC [Member] | First Warrant [Member]                                
Options exercisable period       5 years                        
Stock price per share       $ 0.2568                        
Fair market value, per share       $ 1.00                        
Fair value of warrants       $ 128,400                        
Collaboration Agreement Bio PharmaWorks LLC [Member] | Second Warrant [Member]                                
Options exercisable period   5 years                            
Stock price per share   $ 0.2557                            
Fair market value, per share   $ 2.00                            
Fair value of warrants   $ 127,850                            
Collaboration Agreement Bio PharmaWorks LLC [Member] | Two Options [Member]                                
Issuance of warrants to purchase of common stock           1,000,000                    
Collaboration Agreement Bio PharmaWorks LLC [Member] | Option 1 [Member]                                
Issuance of warrants to purchase of common stock           500,000                    
Collaboration Agreement Bio PharmaWorks LLC [Member] | Option 2 [Member]                                
Issuance of warrants to purchase of common stock           500,000